Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection
Clinical trial NCT02480712 · COMPLETED
Trial details
- NCT number
- NCT02480712
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-04-29
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.